Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Antimicrobial Agents and Chemotherapy|July 27, 2004
Susceptibility of Chlamydia trachomatis to excipients commonly used in topical microbicide formulationsM F Lampe, L C Rohan, M C Skinner, et al.
Infection and Immunity|January 1, 1997
Chlamydia trachomatis major outer membrane protein variants escape neutralization by both monoclonal antibodies and human immune seraM F Lampe, K G Wong, L M Kuehl, et al.
Antimicrobial Agents and Chemotherapy|December 26, 2001
In vitro microbicidal activities of cecropin peptides D2A21 and D4E1 and gel formulations containing 0.1 to 2% D2A21 against Chlamydia trachomatisL M Ballweber, J E Jaynes, W E Stamm, et al.
Infection and Immunity|October 24, 1998
Gamma interferon production by cytotoxic T lymphocytes is required for resolution of Chlamydia trachomatis infectionM F Lampe, C B Wilson, M J Bevan, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1982
Mutational enzymatic resistance of Enterobacter species to beta-lactam antibioticsM F Lampe, B J Allan, B H Minshew, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1976
Reproducibility of control strains for antibiotic susceptibility testingM B Coyle, M F Lampe, C L Aitken, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 1, 1995
Infection with Chlamydia trachomatis lymphogranuloma venereum serovar L1 in homosexual men with proctitis: molecular analysis of an unusual case clusterJ E Bauwens, M F Lampe, R J Suchland, et al.
Antimicrobial Agents and Chemotherapy|May 21, 1998
Killing of Chlamydia trachomatis by novel antimicrobial lipids adapted from compounds in human breast milkM F Lampe, L M Ballweber, C E Isaacs, et al.
JAMA|November 3, 1993
Long-term eradication of Chlamydia trachomatis genital infection after antimicrobial therapy. Evidence against persistent infectionK A Workowski, M F Lampe, K G Wong, et al.
Antimicrobial Agents and Chemotherapy|December 17, 2009
Evaluation of WLBU2 peptide and 3-O-octyl-sn-glycerol lipid as active ingredients for a topical microbicide formulation targeting Chlamydia trachomatisM C Skinner, A O Kiselev, C E Isaacs, et al.
Pageof 3